Logo

Ardy Arianpour

Feb 19, 2016

Celmatix has appointed Ardy Arianpour to its corporate advisory board. Most recently, Arianpour served as chief commercial officer of Pathway Genomics. He has also held senior executive roles at a number of leading personalized medicine companies including Ambry Genetics and the Cogenics division of Clinical Data.


Breaking News
The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.